Salatino Roberto, Franco Marianna, Romero-Toledo Arantxa, Blomqvist Ebba K, Wang Yi, Tsuda Shanel, Burke James M, Szentirmai Oszkar, Janiszewska Michalina
Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf787.
Point mutations in oncogenes and tumor suppressor genes are common drivers of tumorigenesis. Moreover, single nucleotide variants (SNVs) also contribute to cancer by altering the noncoding regions of the genome. However, connecting SNVs to transcriptomic and epigenetic changes at the single-cell level remains challenging. To enable studies of rare populations of cells harboring specific point mutations, we developed STAR-FACS [Specific-To-Allele polymerase chain reaction (PCR) - fluorescence-activated cell sorting (FACS)]. This method allows for cell labeling based exclusively on genomic allele alteration, by in-cell DNA amplification. Labeled cells are then sorted and profiled with bulk or single cell transcriptomics. The labeling method is also compatible with downstream characterization of chromatin features with CUT&Tag (Cleavage Under Targets and Tagmentation). Our proof-of-principle study shows that STAR-FACS can be used to separate cells based on TERT promoter mutation status and is applicable to primary cell lines and dissociated solid tumor tissue. We demonstrate that glioblastoma cell lines derived from the same tumor but harboring distinct TERT promoter SNVs have different transcriptional programs. STAR-FACS provides a novel tool for studies linking subclonal noncoding SNVs with transcriptomic and epigenetic heterogeneity.
癌基因和肿瘤抑制基因中的点突变是肿瘤发生的常见驱动因素。此外,单核苷酸变异(SNV)也通过改变基因组的非编码区域对癌症产生影响。然而,在单细胞水平上将SNV与转录组和表观遗传变化联系起来仍然具有挑战性。为了能够研究携带特定点突变的稀有细胞群体,我们开发了STAR-FACS[等位基因特异性聚合酶链反应(PCR)-荧光激活细胞分选(FACS)]。该方法通过细胞内DNA扩增,仅基于基因组等位基因改变进行细胞标记。然后对标记的细胞进行分选,并用批量或单细胞转录组学进行分析。该标记方法也与使用CUT&Tag(靶向切割和转座)对染色质特征进行下游表征兼容。我们的原理验证研究表明,STAR-FACS可用于根据端粒酶逆转录酶(TERT)启动子突变状态分离细胞,并且适用于原代细胞系和解离的实体瘤组织。我们证明,源自同一肿瘤但携带不同TERT启动子SNV的胶质母细胞瘤细胞系具有不同的转录程序。STAR-FACS为将亚克隆非编码SNV与转录组和表观遗传异质性联系起来的研究提供了一种新工具。